2 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Steven E Arnold, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD Biological/Vaccine: Bacillus Calmette-Guerin (BCG) - Mild Cognitive Impairment, Mild Dementia | Phase 2 | Completed | Steven E Arnold, MD | 15 | 2022-03-25 | 2025-04-13 |
| Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment Niagen, Placebo Comparator - Cognition Disorders in Old Age, Mild Cognitive Impairment | Not applicable | Completed | Steven E Arnold, MD | 61 | 2020-10-30 | 2024-11-29 |
Cognitive Dysfunction (2) · Alzheimer Disease (1)
BCG Vaccine (1) · Biological Products (1) · nicotinamide-beta-riboside (1)
United States (2)